ArticleOncotarget2017

Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer.

Manuela Milani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.